These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23382988)

  • 1. The association of IL28B polymorphism and graft survival in patients with hepatitis C undergoing liver transplantation.
    Allam SR; Krüger B; Mehrotra A; Schiano T; Schröppel B; Murphy B
    PLoS One; 2013; 8(1):e54854. PubMed ID: 23382988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.
    Lange CM; Moradpour D; Doehring A; Lehr HA; Müllhaupt B; Bibert S; Bochud PY; Antonino AT; Pascual M; Farnik H; Shi Y; Bechstein WO; Moench C; Hansmann ML; Sarrazin C; Lötsch J; Zeuzem S; Hofmann WP
    J Hepatol; 2011 Aug; 55(2):322-7. PubMed ID: 21147186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.
    Mueller JL; King LY; Johnson KB; Gao T; Nephew LD; Kothari D; Simpson MA; Zheng H; Wei L; Corey KE; Misdraji J; Lee JH; Lin MV; Gogela NA; Fuchs BC; Tanabe KK; Gordon FD; Curry MP; Chung RT
    Clin Transplant; 2016 Apr; 30(4):452-60. PubMed ID: 26854475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation.
    Biggins SW; Trotter J; Gralla J; Burton JR; Bambha KM; Dodge J; Brocato M; Cheng L; McQueen M; Forman L; Chang M; Kam I; Everson G; Spritz RA; Klintmalm G; Rosen HR
    J Hepatol; 2013 May; 58(5):969-76. PubMed ID: 23333445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables.
    Duarte-Rojo A; Veldt BJ; Goldstein DD; Tillman HL; Watt KD; Heimbach JK; McHutchison JG; Poterucha JJ; Vargas-Vorackova F; Charlton MR
    Transplantation; 2012 Jul; 94(2):197-203. PubMed ID: 22766768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection.
    Charlton MR; Thompson A; Veldt BJ; Watt K; Tillmann H; Poterucha JJ; Heimbach JK; Goldstein D; McHutchison J
    Hepatology; 2011 Jan; 53(1):317-24. PubMed ID: 21254179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CC genotype at rs12979860 of IL28B is associated with lower risk of new-onset diabetes after transplantation in adult patients with liver transplantation for hepatitis C cirrhosis.
    Duca AM; de la Fuente S; Citores MJ; Cuenca AB; Cisneros E; Escamilla N; Baños I; Vilches C; Cuervas-Mons V
    Transplant Proc; 2014 Nov; 46(9):3114-6. PubMed ID: 25420838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor and recipient IL28B polymorphisms in HCV-infected patients undergoing antiviral therapy before and after liver transplantation.
    Coto-Llerena M; Pérez-Del-Pulgar S; Crespo G; Carrión JA; Martínez SM; Sánchez-Tapias JM; Martorell J; Navasa M; Forns X
    Am J Transplant; 2011 May; 11(5):1051-7. PubMed ID: 21466653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocellular carcinoma, graft fibrosis, and posttransplant antiviral therapy.
    Eurich D; Boas-Knoop S; Bahra M; Neuhaus R; Somasundaram R; Neuhaus P; Neumann U; Seehofer D
    Transplantation; 2012 Mar; 93(6):644-9. PubMed ID: 22411462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.
    Lim KB; Sima HR; Fiel MI; Khaitova V; Doucette JT; Chernyiak M; Ahmad J; Bach N; Chang C; Grewal P; Kim-Schluger L; Liu L; Odin J; Perumalswami P; Florman SS; Schiano TD
    World J Gastroenterol; 2015 May; 21(20):6236-45. PubMed ID: 26034358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant.
    Firpi RJ; Dong H; Clark VC; Soldevila-Pico C; Morelli G; Cabrera R; Norkina O; Shuster JJ; Nelson DR; Liu C
    Liver Int; 2013 Jan; 33(1):72-8. PubMed ID: 23107586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of severe hepatitis C virus recurrence after liver transplantation in patients with a T allele of IL28B rs12979860.
    Cisneros E; Baños I; Citores MJ; Duca A; Salas C; Noblejas A; Cañizares M; Millán I; Cuervas-Mons V; Vilches C
    Transplantation; 2012 Aug; 94(3):275-80. PubMed ID: 22790387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFNL4 polymorphism predicts response to hepatitis C treatment after liver transplantation.
    Fernández-Carrillo C; Coto-Llerena M; González P; Crespo G; Mensa L; Caro-Pérez N; Gambato M; Navasa M; Forns X; Pérez-del-Pulgar S
    J Clin Virol; 2014 Oct; 61(2):282-5. PubMed ID: 25130512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL28B polymorphisms of both recipient and donor cooperate to influence IFN treatment response in HCV recurrence after liver transplantation, but IL28B SNPs of the recipient play a major role in IFN-induced blocking of HCV replication.
    Barbera F; Russelli G; Pipitone L; Pietrosi G; Corsale S; Vizzini G; Gridelli B; Conaldi PG
    New Microbiol; 2015 Apr; 38(2):201-10. PubMed ID: 25938745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of IL28B polymorphisms in liver biopsies obtained after liver transplantation.
    Coto-Llerena M; Crespo G; González P; Koutsoudakis G; Miquel R; Navasa M; Forns X; Pérez-del-Pulgar S
    J Hepatol; 2012 Feb; 56(2):355-8. PubMed ID: 21889467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation.
    Eurich D; Boas-Knoop S; Ruehl M; Schulz M; Carrillo ED; Berg T; Neuhaus R; Neuhaus P; Neumann UP; Bahra M
    Liver Transpl; 2011 Mar; 17(3):289-98. PubMed ID: 21384511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recipient IL28B polymorphism is an important independent predictor of posttransplant diabetes mellitus in liver transplant patients with chronic hepatitis C.
    Veldt BJ; Duarte-Rojo A; Thompson AJ; Watt KD; Heimbach JK; Tillmann HL; Goldstein DD; McHutchison JG; Charlton MR
    Am J Transplant; 2012 Mar; 12(3):737-44. PubMed ID: 22300408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-28b CC genotype predicts early treatment response and CT/TT genotypes predicts non-response in patients infected with HCV genotype 3.
    Gupta AC; Trehanpati N; Sukriti S; Hissar S; Midha V; Sood A; Sarin SK
    J Med Virol; 2014 Apr; 86(4):707-12. PubMed ID: 24415442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of IL28B SNPs rs12979860 and rs8099917 on Hepatitis C Virus-RNA Status in Donors/Recipients of Living Donor Liver Transplantation.
    Chiu KW; Nakano T; Chen KD; Lin CC; Hu TH; Goto S; Chen CL
    PLoS One; 2016; 11(6):e0156846. PubMed ID: 27275739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C.
    Fukuhara T; Taketomi A; Motomura T; Okano S; Ninomiya A; Abe T; Uchiyama H; Soejima Y; Shirabe K; Matsuura Y; Maehara Y
    Gastroenterology; 2010 Nov; 139(5):1577-85, 1585.e1-3. PubMed ID: 20708617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.